Nanomedicines Market, By Application (Cardiovascular, Anti-inflammatories, Anti-infectives, Neurology, Oncology, Others (dental, orthopedic, urology, ophthalmic)), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) -

Nanomedicines Market, By Application (Cardiovascular, Anti-inflammatories, Anti-infectives, Neurology, Oncology, Others (dental, orthopedic, urology, ophthalmic)), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Nanomedicine products have applications in drug delivery, in vivo imaging, in vitro diagnostics, regenerative medicine, dental, medical devices, and dermal applications. Major drivers for the global nanomedicine market constitutes of increasing government support as well as continuous increase in the occurrence of chronic diseases including diabetes, obesity, cancer, orthopedic diseases, and kidney disorder. Furthermore, major players in the global nanomedicine market are focused on R&D of new products to expand their product portfolio.
Key features of the study:
This report provides in-depth analysis of the Global Nanomedicines market and provides market size (US$ billion) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the Global Nanomedicines market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, Abbott Laboratories, CombiMatrix Corporation, Clene Nanomedicine, Inc., Cellics Therapeutics, Inc., Nanobiotix S.A, Celgene Corporation, GE Healthcare, NanoViricides, Inc., Johnson & Johnson, Mallinckrodt plc., Sirnaomics Inc., Precision NanoSystems Inc., Merck & Company Inc., Nanosphere, Inc., Pfizer Inc., and Sigma-Tau Pharmaceuticals Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The Global Nanomedicines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Nanomedicines market
Detailed Segmentation:
Global Nanomedicines Market, By Application:
Cardiovascular
Anti-inflammatories
Anti-infectives
Neurology
Oncology
Others (dental, orthopedic, urology, ophthalmic)
Global Nanomedicines Market, By Region:
North America
By Application
Cardiovascular
Anti-inflammatories
Anti-infectives
Neurology
Oncology
Others (dental, orthopedic, urology, ophthalmic)
By Country
U.S.
Canada
Latin America
By Application
Cardiovascular
Anti-inflammatories
Anti-infectives
Neurology
Oncology
Others (dental, orthopedic, urology, ophthalmic)
By Country
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Application
Cardiovascular
Anti-inflammatories
Anti-infectives
Neurology
Oncology
Others (dental, orthopedic, urology, ophthalmic)
By Country
U.K.
Germany
France
Spain
Italy
Russia
Rest of Europe
Asia Pacific
By Application
Cardiovascular
Anti-inflammatories
Anti-infectives
Neurology
Oncology
Others (dental, orthopedic, urology, ophthalmic)
By Country
China
Japan
India
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Application
Cardiovascular
Anti-inflammatories
Anti-infectives
Neurology
Oncology
Others (dental, orthopedic, urology, ophthalmic)
By Country
GCC Countries
Israel
Rest of Middle East
Africa
By Application
Cardiovascular
Anti-inflammatories
Anti-infectives
Neurology
Oncology
Others (dental, orthopedic, urology, ophthalmic)
By Country
North Africa
Central Africa
South Africa
Company Profiles
Abbott Laboratories *
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
CombiMatrix Corporation
Clene Nanomedicine, Inc.
Cellics Therapeutics Inc.
Nanobiotix S.A
Celgene Corporation
GE Healthcare
NanoViricides, Inc.
Johnson & Johnson
Mallinckrodt plc.
Sirnaomics Inc.
Precision NanoSystems Inc.
Merck & Company Inc.
Nanosphere, Inc.
Pfizer Inc.
Sigma-Tau Pharmaceuticals Inc.
“*” marked represents similar segmentation in other categories in the respective section.